Coronary risk factors in acute Kawasaki disease: Correlation of serum immunoglobulin levels with coronary complications

Pediatrics International

Volumn 40, Issue 3, 1998, Pages 218-225

  Sawaji, Yoichi ^a   Haneda, Noriyuki ^a   Yamaguchi, Seiji ^a   Kajino, Yasuhisa ^b   Kishida, Kenji ^c   Seto, Shiro ^d   Konishi, Nakao ^e   Waki, Kenji ^e   Baba, Kiyoshi ^e   Arisawa, Kokichi ^f   Kamiya, Tetsuro ^g   Mori, Chuzo ^h  

^a SHIMANE UNIVERSITY   (Japan)

^b Masuda Red Cross Hospital   (Japan)

^c KOKURA MEMORIAL HOSPITAL   (Japan)

^d Kishiwada City Hospital   (Japan)

^e KURASHIKI CENTRAL HOSPITAL   (Japan)

^f NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^h Kyoto Bunkyo Junior College   (Japan)

Author keywords

Coronary aneurysm; IgG z score; Intravenous gamma globulin; Kawasaki disease; Serum IgG

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY RISK; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; FEMALE; GAMMA-GLOBULINS; HUMANS; IMMUNOGLOBULIN G; INFANT; INFUSIONS, INTRAVENOUS; JAPAN; LOGISTIC MODELS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; ODDS RATIO; SEVERITY OF ILLNESS INDEX;

EID: 7144235794     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1998.tb01915.x     Document Type: Article

References (26)

1. Kawasaki T. Acute febrile mucocutaneous lymph dose syndrome: Clinical observations of 50 cases. Jpn. J. Allergy 1967; 16: 178–222.
2. Kawasaki T., Kosaki F. Okawa S., Shigematsu I., Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MCLS) prevailing in Japan. Pediatrics 1974; 54: 271–6.
3. Morens Dm, Anderson Lh, Hurwitz Es. National surveillance of Kawasaki disease. Pediatrics 1980; 65: 100–7.
4. Kato H., Ichinose E., Kawasaki T. Myocardial infarction in Kawasaki disease: Clinical analyses in 195 cases. J. Pediatr. 1986; 108: 923–7.
5. Kato H., Ichinose E., Yoshioka F. et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am. J. Cardiol. 1982; 49: 1758–66.
6. Fujiwara H., Chen Ch, Fujiwara T., Nishioka K., Kawai C., Hamashima Y. Clinicopathologic study of abnormal Q waves in Kawasaki disease (mucocutaneous lymph node syndrome): An infantile cardiac disease with myocarditis and myocardial infarction. Am. J. Cardiol. 1980; 45: 797–805.
7. Furusho K. Kamiya T., Nakano H., Kiyosawa N., Shinomiya K., Hayashidera T. High-dose intravenous gamma-globulin for Kawasaki disease. Lancet 1984; 2: 1055–8.
8. Newberger Jw, Takahashi M. Burns Jc, Beiser As, Chung Kj, Duffy Ce. The treatment of Kawasaki syndrome with intravenous gamma-globulin. N. Engl. J. Med. 1986; 315: 341–7.
9. Rowley Ah, Duffy Ce, Shulman St. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma-globulin therapy. J. Pediatr. 1988; 113: 290–4.
10. Nagashima M., Matsushima M., Matsuoka H., Ogawa A., Okumura N. High dose gamma globulin therapy for Kawasaki disease. J. Pediatr. 1987; 110: 710–12.
11. Fukushima H., Yamagishi H. The treatment of Kawasaki disease with intravenous globulin. J. Pediatr. Pract. 1994; 57: 2263–8.
12. Engle Ma, Fatica Ns, Bussel Jb, O'Loughlin Je, Snyder Ms, Lesser Ml. Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease. Am. J. Dis. Child. 1989; 143: 1300–4.
13. Dajani As Taubert Ka. Gerber Ma et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993; 87: 1776–80.
14. Barron Ks, Murphy Dj, Silverman Ed et al. Treatment of Kawasaki syndrome: A comparison of two dosage regimens of intravenously administered immune globulin. J. Pediatr. 1990; 117: 638–44.
15. Newberger Jw, Takahashi M., Beiser As et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 1991; 324: 1633–9.
16. Nakano H. Ueda K., Saito A., Tsuchitani Y., Kawamori J., Miyake T. Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms. Am. J. Cardiol. 1986; 58: 739–42.
17. Harada K. Kawasaki disease and gamma globulin: the indication of intravenous gamma globulin. Prog. Med. 1990; 10: 23–7.
18. Iwasa M., Yamori N., Ando T. Takeda S., Fujita N., Sasaki Y. Selection of high risk patients for gammaglobulin therapy in Kawasaki disease. J. Jn Pediatr. Soc. 1994; 98: 1226–34.
19. Ichida F., Fatica Ns, Engle Ma, O'Loughlin Je, Klein Aa, Snyder Ms. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: Risk factors and role of aspirin. Pediatrics 1987; 80: 828–35.
20. Kato H., Hara T., Inoue O. et al. Current issues in Kawasaki disease. Acta Paediatr. Jpn. 1993; 35: 464–71.
21. Tatara K., Kusakawa S. Long-term prognosis of giant coronary aneurysm in Kawasaki disease. J. Pediatr. 1987; 111: 705–10.
22. Fujiwara T., Fujiwara H., Hamashima Y. Size of coronary aneurysm as a determinant factor of the prognosis in Kawasaki disease: Clinicopathologic study of coronary aneurysm. In: Shulman St (ed). Kawasaki Disease: Progress in Clinical ana Biological Research. Vol. 250. Alan R. Liss, New York, 1987; 519–20.
23. Fujiwara T., Fujiwara H., Hamashima Y. Frequency and size of coronary arterial aneurysm at necropsy in Kawasaki disease. Am. J. Cardiol. 1987; 59: 808–11.
24. Kobayashi N., Matumoto S., Kobayashi K. et al. Clinical Immunology of Pediatric Diseases. Igakusha Ltd, Tokyo, 1975; 439–43.
25. Hayasibara H., Tanimoto K., Nagata I., Harada Y., Shiraki K. Normal levels of IgG subclass in childhood determined by a sensitive ELISA. Acta Paediatr. Jpn. 1993; 35: 113–17.
26. Leung Dym, Burns Jc, Newberger Jw, Geha Rs. Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J. Clin. Invest. 1987; 79: 468–72.